SiteOne Therapeutics
Developing novel therapeutics focused on the peripheral nervous system,.
Employees
Enterprise value
$400—600m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
Amgen(exited)
Mission Bay Capital(exited)
NEXT Frontier Capital(exited)
BioBrit(exited)
Sears Capital Management(exited)
Bay Capital(exited)
National Institute on Drug Abuse(exited)
OrbiMed(exited)
Wellington Management(exited)
Mission BioCapital(exited)
BSQUARED Capital(exited)
Novo Holdings(exited)
| USD | 2020 | 2021 | 2023 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads